Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch

Journal of Nutrition

Volumn 141, Issue 5, 2011, Pages 883-889

  McOrist, Alexandra L ^a   Miller, Rosalind B ^a   Bird, Anthony R ^a   Keogh, Jennifer B ^a   Noakes, Manny ^a   Topping, David L ^a   Conlon, Michael A ^a  

^a CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; AMMONIA; BUTYRIC ACID; NONSTARCH POLYSACCHARIDE; POLYSACCHARIDE; PROPIONIC ACID; RESISTANT STARCH; STARCH; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXCRETION; FAT INTAKE; FECES ANALYSIS; FECES LEVEL; FEMALE; FIBER; FOOD ANALYSIS; HUMAN; HUMAN EXPERIMENT; MALE; MOISTURE; NORMAL HUMAN; PH; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; WEIGHT;

ADULT; AGED; AMMONIA; BODY MASS INDEX; BUTYRATES; CROSS-OVER STUDIES; DIET; FATTY ACIDS, VOLATILE; FECES; FEMALE; FERMENTATION; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; SEX CHARACTERISTICS; STARCH; WATER;

BACTERIA (MICROORGANISMS);

EID: 79955492715     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.128504     Document Type: Article

References (42)

1. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 1991;70:443-59.
2. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-64.
3. Brouns F, Kettlitz B, Arrigoni E. Resistant starch and the "butyrate revolution". Trends Food Sci Technol. 2002;13:251-61.
4. Van Munster IP, Tangerman A, Nagengast FM. Effect of resistant starch on colonic fermentation, bile acid metabolism and mucosal proliferation. Dig Dis Sci. 1994;39:834-42.
5. Dronamraju SS, Coxhead JM, Kelly SB, Burn J, Mathers JC. Cell kinetics and gene expression changes in colo-rectal cancer patients given resistant starch: a randomised control trial. Gut. 2009;58:413-20.
6. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008;27:104-19.
7. Caderni G, Luceri C, Lancioni L, Tessitore L, Dolara P. Slow-release pellets of sodium butyrate increase apoptosis in the colon of rats treated with azoxymethane, without affecting aberrant crypt foci and colonic proliferation. Nutr Cancer. 1998;30:175-81.
8. Le Leu RK, Brown IL, Hu Y, Morita T, Esterman A, Young GP. Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats. Carcinogenesis. 2007;28:240-5.
9. Clarke JM, Topping DL, Bird AR, Young GP, Cobiac L. Effects of high amylose maize starch and butyrylated maize starch on azoxymethane-induced intestinal cancer in rats. Carcinogenesis. 2008;29: 2190-4.
10. Toden S, Bird AR, Topping DL, Conlon MA. Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol Ther. 2007;6:253-8.
11. Bajka BH, Clarke JM, Cobiac L, Topping DL. Butyrylated starch protects colonocyte DNA against dietary protein-induced DNA damage in rats. Carcinogenesis. 2008;29:2169-74.
12. Weaver GA, Krause JA, Miller TL, Wolin MJ. Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fermentation; cornstarch fermentation rates correlate negatively with methanogenesis. Am J Clin Nutr. 1992;55:70-7.
13. Segal I, Hassan H, Walker AR, Becker P, Braganza J. Fecal short chain fatty acids in South African urban Africans and whites. Dis Colon Rectum. 1995;38:732-4.
14. Ahmed R, Segal I, Hassan H. Fermentation of dietary starch in humans. Am J Gastroenterol. 2000;95:1017-20.
15. Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, Norat T, Clavel-Chapelon F, Kesse E, Nieters A, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496-501.
16. Schatzkin A, Lanza E, Corle D, Lance P, Iber F, Caan B, Shike M, Weissfeld J, Burt R, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000;342:1149-55.
17. Larsson SC, Giovannucci E, Bergkvist L, Wolk A. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer. 2005;92:1803-7.
18. Topping D. Cereal complex carbohydrates and their contribution to human health. J Cereal Sci. 2007;46:220-9.
19. Baghurst PA, Baghurst KI, Record SJ. Dietary fibre, non-starch polysaccharides and resistant starch: a review. Food Aust. 1996;48: S3-35.
20. Muir JG, Yeow EGW, Keogh J, Pizzey C, Bird AR, Sharpe K, O'Dea K, Macrae F. Combining wheat bran with resistant starch has more beneficial effects on fecal indices than does wheat bran alone. Am J Clin Nutr. 2004;79:1020-8.
21. Cummings JH, Beatty ER, Kingman SM, Bingham SA, Englyst HN. Digestion and physical properties of resistant starch in the human large bowel. Br J Nutr. 1996;75:733-47.
22. McOrist AL, Abell GC, Cooke C, Nyland K. Bacterial population dynamics and faecal short chain fatty acid (SCFA) concentrations in healthy humans. Br J Nutr. 2008;100:138-46.
23. Bird AR, Vuaran MS, King RA, Noakes M, Keogh J, Morell MK, Topping DL. Wholegrain foods made from a novel high-amylose barley variety (Himalaya 292) improve indices of bowel health in human subjects. Br J Nutr. 2008;99:1032-40.
24. Chaney AL, Marbach EP. Modified reagents for determination of urea and ammonia. Clin Chem. 1962;8:130-2.
25. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0; 2010. Available from: http://www.R-project.org/.
26. Cummings JH, Pomare EW, Branch WJ, Naylor CP, MacFarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987;28:1221-7.
27. Topping DL, Illman RJ, Clarke J, Trimble RP, Jackson KA, Marsono Y. Dietary fat and fiber alter large bowel and portal venous volatile fatty acids and plasma cholesterol but not biliary steroids in pigs. J Nutr. 1993;123:133-43.
28. Bird AR, Vuaran M, Brown I, Topping DL. Two high amylose maize starches with different amounts of resistant starch vary in their effects on fermentation, tissue and digesta mass accretion, and bacterial populations in the large bowel of pigs. Br J Nutr. 2007;97: 137-44.
29. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-31.
30. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-5.
31. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA. 2008;105:16767-72.
32. Cani PD, Delzenne NM. Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol. 2009;9:737-43.
33. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26:5-11.
34. Cummings JH, Bingham SA, Heaton KW, Eastwood MA. Faecal weight, colon cancer risk, and dietary-intake of nonstarch polysaccharides (dietary fibre). Gastroenterology. 1992;103:1783-9.
35. Birkett AM, Jones GP, de Silva AM, Young GP, Muir JG. Dietary intake and faecal excretion of carbohydrate by Australians: importance of achieving stool weights greater than 150 g to improve faecal markers relevant to colon cancer risk. Eur J Clin Nutr. 1997;51:625-32.
36. Lampe JW, Fredstrom SB, Slavin JL, Potter JD. Sex differences in colonic function: a randomised trial. Gut. 1993;34:531-6.
37. McBurney MI. Starch malabsorption and stool excretion are influenced by the menstrual cycle in women consuming low-fibre Western diets. Scand J Gastroenterol. 1991;26:880-6.
38. Australian Institute of Health and Welfare. Cancer in Australia: an overview; 2008 [cited 2011 Feb 10]. Available from: http://www.aihw.gov.au/publications/index.cfm/title/10607.
39. Lewis SJ, Heaton KW. The intestinal effects of bran-like plastic particles: is the concept of 'roughage' valid after all? Eur J Gastroenterol Hepatol. 1997;9:553-7.
40. Lewis SJ, Heaton KW. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut. 1997;41:245-51.
41. Visek WJ. Diet and cell growth modulation by ammonia. Am J Clin Nutr. 1978;31 Suppl 10:S216-20.
42. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol. 2007;73:1073-8.